History
Cell, gene and immunological therapies comprise the most sophisticated treatments modern technology has developed. While their success has been deemed a ‘miracle’, however, unfortunately, their cost is exorbitant often running into millions of dollars which is not sustainable for any individual patient, society or country.
MedTherapy Biotech was founded by experts in the cancer field with a mission to make this treatment so affordable and accessible that almost every cancer patient would be able to afford it.
In 2018, committed experts from Harvard University including Harvard Medical School and Harvard Business School, and former Novartis executives founded this biotechnology company and developed next-generation innovative technologies to make the cumbersome manufacturing process more efficient and cost-effective.
With its technology development and headquarters in Boston, USA and global manufacturing facilities in New Delhi India, aided with our nextgeneration technology and a globally renowned team of cancer experts, we are bringing this life-saving cancer gene therapy to every cancer patient on this planet.
Mission & Vision
Our mission is to make cancer gene therapy accessible and affordable for all cancer patients in the world.
Our vision is to bring together all like-minded organizations - private, public, academic, and non-profits in US and globally to develop more innovative streamlined processes, technologies and partnerships to manufacture these sophisticated medical therapies and made affordable for every patient in the world.
